Contact Us: 01282 426380
KM Financial Solutions | UPDATE 1-Regeneron/Sanofi heart drug succeeds in major trial; Will insurers pay?
11856
post-template-default,single,single-post,postid-11856,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 1-Regeneron/Sanofi heart drug succeeds in major trial; Will insurers pay?

09 Mar UPDATE 1-Regeneron/Sanofi heart drug succeeds in major trial; Will insurers pay?

Posted at 16:30h in News by
0 Likes
March 10 (Reuters) – A potent, expensive cholesterol drug
sold by Regeneron Pharmaceuticals and Sanofi
significantly reduced major adverse heart events in a huge study
presented on Saturday but it remains to be seen whether the new
data will prompt insurers to pay for increased use of the
medicine.

No Comments

Sorry, the comment form is closed at this time.